KR960021039A - Pharmaceutical composition for improving liver function and treating hepatitis, containing extracts of the materiaceae - Google Patents

Pharmaceutical composition for improving liver function and treating hepatitis, containing extracts of the materiaceae Download PDF

Info

Publication number
KR960021039A
KR960021039A KR1019940035685A KR19940035685A KR960021039A KR 960021039 A KR960021039 A KR 960021039A KR 1019940035685 A KR1019940035685 A KR 1019940035685A KR 19940035685 A KR19940035685 A KR 19940035685A KR 960021039 A KR960021039 A KR 960021039A
Authority
KR
South Korea
Prior art keywords
water
molecular weight
liver function
pharmaceutical composition
treating hepatitis
Prior art date
Application number
KR1019940035685A
Other languages
Korean (ko)
Other versions
KR100328467B1 (en
Inventor
한영복
김정룡
경홍기
김춘원
김종배
홍은경
최희숙
이치호
Original Assignee
한영복
김순배
태림제약 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한영복, 김순배, 태림제약 주식회사 filed Critical 한영복
Priority to KR1019940035685A priority Critical patent/KR100328467B1/en
Publication of KR960021039A publication Critical patent/KR960021039A/en
Application granted granted Critical
Publication of KR100328467B1 publication Critical patent/KR100328467B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/84—Valerianaceae (Valerian family), e.g. valerian
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

본 발명은 마타리과(Valerianaceae) 식물의 총추출물 또는 그의 수용성 저분자량 분획을 함유함을 특징으로 하는 간기능 개선 및 간염 치료용 의약 조성물에 관한 것이다. 본 발명에 따르는 마타리과 식물의 총추출물 또는 그의 수용성 저분자량 분획은 약물의존성이 매우 낮고 부작용이 거의 없으며, 숙주의 면역기능 부전을 회복시키고 간염치료와 손상된 간세포의 재생 및 간장 보호기능을 가지고 있다.The present invention relates to a pharmaceutical composition for improving liver function and treating hepatitis, which comprises a total extract of a Valerianaceae plant or a water-soluble low molecular weight fraction thereof. The total extract of the cultivars of the present invention or its water-soluble low molecular weight fraction has very low drug dependence and almost no side effects, restores immune dysfunction of the host, has hepatitis treatment and regeneration of damaged hepatocytes and hepatoprotective function.

Description

마타리과 식물의 추출물을 함유하는 간기능 개선 및 간염 치료용 의약 조성물Pharmaceutical composition for improving liver function and treating hepatitis, containing extracts of the materiaceae

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (7)

마타리과(Vdedmaceae) 식물의 총추출물 또는 그의 수용성 저분자량 분획을 유효성분으로 함유함을 특징으로 하는 간기능 개선 및 간염치료용 의약 조성물.A pharmaceutical composition for improving liver function and treating hepatitis, characterized by containing a total extract of the plant of the Materiaceae (Vdedmaceae) or a water-soluble low molecular weight fraction thereof as an active ingredient. 제1항에 있어서, 마타리과 식물의 총추출물이 물에 의한 추출물임을 특징으로 하는 간기능 개선 및 간염 치료용 의약 조성물.The pharmaceutical composition for improving liver function and treating hepatitis according to claim 1, wherein the total extract of the plant is a water extract. 제1항에 있어서, 마타리과 식물의 추출물중의 수용성 저분자량 분획을 유효성분으로 함유함을 특징으로 하는 간기능 개선 및 간염 치료용 의약 조성물.2. The pharmaceutical composition for improving liver function and treating hepatitis according to claim 1, which comprises a water-soluble low molecular weight fraction in the extract of Matariaceae as an active ingredient. 제3항에 있어서, 수용성 저분자량 분획이 분자량 50000미만의 저분자량 다당류임을 특징으로 하는 간기능 개선 및 간염 치료용 의약 조성물.The pharmaceutical composition for improving liver function and treating hepatitis according to claim 3, wherein the water-soluble low molecular weight fraction is a low molecular weight polysaccharide having a molecular weight of less than 50000. 제1항에 있어서, 추가로 다른 면역중간제 또는 간기능 개선제를 함유함을 특징으로 하는 간기능 개선 및 간염 치료용 의약 조성물.The pharmaceutical composition for improving liver function and treating hepatitis according to claim 1, which further contains other immune intermediates or liver function improving agents. 마타리과 식물을 물로 추출하고, 수추출물을 여과하여 여액을 증기압(121℃/15파운드/in a2)에 포화시켜 단백질을 응고시켜 침전으로 석출시킨 후에 원심분리 하여 제거하고, 용매로 처리하여 섬유질, 수지 및 용매-가용성 불순물을 제거하고, 수층을 정제한 후에 동결건조시킴을 특징으로 하는 마타리과 식물의 충추출물을 제조하는 방법.Matariaceae is extracted with water, the water extract is filtered and the filtrate is saturated with vapor pressure (121 ℃ / 15 pounds / in a 2 ), the protein is coagulated, precipitated by precipitation, centrifuged to remove, treated with a solvent, fibrous, A method for preparing packed extracts of materiaceae, characterized in that the resin and solvent-soluble impurities are removed and the aqueous layer is purified and lyophilized. 마타리과 식물을 물로 추출하고, 수추출물을 여과하여 여액을 증기압(121℃/15파운드/in a2)에 포화시켜 단백질을 응고시켜 침전으로 석출시킨 후에 원심분리 하여 제거하고, 용매로 처리하여 섬유질, 수지 및 용매-가용성 불순물을 제거하고, 수충을 정제한 후에, 계속해서 수충에 에탄올을 가하여 여과하고, 여액을 중화시키고 한외여과하여 여과된 분자량 50000미만의 분획을 회수하여 동결건조시킴을 특징으로 하여 마타리과 식물의 추출몰의 수용성 저분자량 분획을 제조하는 방법.Matariaceae is extracted with water, the water extract is filtered and the filtrate is saturated with vapor pressure (121 ℃ / 15 pounds / in a 2 ), the protein is coagulated, precipitated by precipitation, centrifuged to remove, treated with a solvent, fibrous, After removing the resin and the solvent-soluble impurities, purifying the water larvae, the ethanol was subsequently added to the water filtration, the filtrate was neutralized, and ultrafiltration was performed to recover the fractions of the molecular weight less than 50000 and freeze-dried. A method for producing a water soluble low molecular weight fraction of the extract moles of materiaceae. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019940035685A 1994-12-21 1994-12-21 Composition for improving liver function and treating hepatitis containing extract of valerianaceae KR100328467B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019940035685A KR100328467B1 (en) 1994-12-21 1994-12-21 Composition for improving liver function and treating hepatitis containing extract of valerianaceae

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019940035685A KR100328467B1 (en) 1994-12-21 1994-12-21 Composition for improving liver function and treating hepatitis containing extract of valerianaceae

Publications (2)

Publication Number Publication Date
KR960021039A true KR960021039A (en) 1996-07-18
KR100328467B1 KR100328467B1 (en) 2002-06-28

Family

ID=37478576

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940035685A KR100328467B1 (en) 1994-12-21 1994-12-21 Composition for improving liver function and treating hepatitis containing extract of valerianaceae

Country Status (1)

Country Link
KR (1) KR100328467B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001082941A1 (en) * 2000-05-02 2001-11-08 Medvill Co., Ltd. Composition for treatment of b-type hepatitis and liver cirrhosis

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001082941A1 (en) * 2000-05-02 2001-11-08 Medvill Co., Ltd. Composition for treatment of b-type hepatitis and liver cirrhosis
KR100389131B1 (en) * 2000-05-02 2003-06-25 (주) 메드빌 Composition for B type Hepatitis and Cirrhosis of Liver Comprising Phellodendron amurense Rupr. cortex and Patrinia scabiosaefolia FISCH. Extract

Also Published As

Publication number Publication date
KR100328467B1 (en) 2002-06-28

Similar Documents

Publication Publication Date Title
JPS5461112A (en) Oncostatic polysaccharide* its preparation* and oncostatic drugs containing it as an effective component
JPS5828247A (en) Purifying method of stevioside solution
DE69621342D1 (en) SIMPLIFIED SOLVENT EXTRACTION OF POLYHYDROXYALKANOATS FROM BIOMASS BY USING A MARGINAL NON-SOLVENT FOR PHA
KR960021039A (en) Pharmaceutical composition for improving liver function and treating hepatitis, containing extracts of the materiaceae
KR910015307A (en) Immunomodulating polysaccharides obtained from Astragalus membranaseus and pharmaceutical compositions comprising the same
DE50107344D1 (en) PREPARATION OF POLYGALACTURONIDES AND THEIR USE AS FOOD ADDITIVES
KR910000176A (en) Angiogenesis inhibitors
ATE272322T1 (en) HIGHLY FOAMING COFFEE FRACTION AND METHOD FOR THE PRODUCTION THEREOF
IE39246B1 (en) Process for preparing a purified extract of quillata bark
JPH11506095A (en) Extract from ginkgo leaves
CN101224224A (en) Method for extracting crude flavone and flavone glycoside from ginkgo leafs
KR970032502A (en) Phalanx extract and its manufacturing method
KR960021047A (en) Method for preparing fractions with coagulation action from casualties
JP3205581B2 (en) Collagen crosslinking inhibitor
KR960000244A (en) Extract of Philiostigma Tonninji, Method of Use thereof, and Composition Comprising the Same
GB1564592A (en) Arterial polysaccharide complex process for its preparation and its use in human therapy
US4147691A (en) Process for the extraction and purification of cesalin
SU1666457A1 (en) Method for obtaining pectin
KR970064612A (en) Immune enhancer composition containing Korean mistletoe extract
KR840005741A (en) Method for preparing a substance having anticancer and immunostimulatory action
KR940013519A (en) Method of Extracting and Purifying Active Active Material from Ginkgo Leaves
KR940006596A (en) Method for Extracting and Purifying Flavonoid Compounds from Ginkgo Leaves
KR970005303A (en) Mugwort Protein Polysaccharide and Extract Purification Method thereof
JPH0678366B2 (en) Manufacturing method of chrysanthemum polysaccharides
KR950028775A (en) Preparation method of gut extract

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
N231 Notification of change of applicant
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20110112

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20110414

Year of fee payment: 13

EXPY Expiration of term